Brucellar spondylitis: review of 35 cases and literature survey

Clin Infect Dis. 1999 Dec;29(6):1440-9. doi: 10.1086/313524.

Abstract

Thirty-five patients aged 14-74 years (average, 54 years) who had brucellar spondylitis were treated between January 1991 and December 1997. The time from onset of symptoms to diagnosis of spondylitis ranged from 1 week to 8 months (median, 9 weeks). Back or neck pain (100% of patients), fever (66%), and constitutional symptoms (57%) were the most common symptoms. Cultures of blood specimens from 26 patients (74%) were positive for Brucella melitensis. The duration of antimicrobial therapy (median, 120 days; range, 45-535 days) varied according to clinical response and the presence of epidural and paravertebral masses. One of the 35 patients underwent surgical treatment of a spinal epidural abscess. Therapy failed for 9 patients (26%; 95% confidence interval [CI], 12%-43%), and 5 (14%; 95% CI, 5%-30%) had a relapse. There were no deaths or severe sequelae in this study. Brucellar spondylitis causes considerable suffering and absenteeism from work, but long-term clinical responses are favorable.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aminoglycosides / therapeutic use
  • Brucella melitensis / drug effects
  • Brucella melitensis / isolation & purification*
  • Brucellosis / complications
  • Brucellosis / drug therapy
  • Brucellosis / microbiology*
  • Doxycycline / therapeutic use
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Follow-Up Studies
  • Gentamicins / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Spondylitis / complications
  • Spondylitis / drug therapy
  • Spondylitis / pathology*
  • Streptomycin / therapeutic use

Substances

  • Aminoglycosides
  • Gentamicins
  • Doxycycline
  • Streptomycin